Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alaunos Therapeutics, Inc.

NASDAQ: TCRT · Life Sciences · 6 alerts · CIK 1107421

Share price
$1.60Close, Nov 16
Market cap
$4.06M
Shares outstanding
2.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alaunos Therapeutics, Inc. filings on SEC EDGAR ↗

4:42 PM ET 10-Q
Financial Results

Alaunos Therapeutics Q3 2026 Results: Net Loss of $772K, Loss Narrows

Alaunos Therapeutics reported a net loss of $2.7 million for the nine months ended September 30, 2026, as it transitioned from TCR therapies to pulmonary arterial hypertension treatments. The company's cash position decreased to $615,000, and it recently acquired Velaris Therapeutics in October 2026 to bolster its pipeline.

Key figure
Net loss $772K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.